Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 19018 [2012-7545]

Download as PDF mstockstill on DSK4VPTVN1PROD with NOTICES 19018 Federal Register / Vol. 77, No. 61 / Thursday, March 29, 2012 / Notices Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines, which have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction, which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, most recently, August 3, 2011, and will expire on August 3, 2013. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters To Be Discussed: The agenda for the conference call includes: SEC Petition for Feed Materials Production Center (Fernald, Ohio); Subcommittee and Work Group Updates; SEC Petition Evaluations Update for the June 2012 Advisory Board Meeting; and Board Correspondence. The agenda is subject to change as priorities dictate. Because there is not a verbal public comment period, written comments may be submitted. Any written comments received will be included in the official record of the meeting and should be submitted to the contact person below in advance of the meeting. Contact Person for More Information: Theodore M. Katz, M.P.A., Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., Mailstop: E–20, Atlanta, Georgia 30333, Telephone (513)533–6800, Toll Free 1(800) CDC–INFO, Email ocas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. VerDate Mar<15>2010 17:14 Mar 28, 2012 Jkt 226001 Dated: March 22, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Dated: March 23, 2012. Elizabeth Millington, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012–7554 Filed 3–28–12; 8:45 am] [FR Doc. 2012–7551 Filed 3–28–12; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC) Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the CDC announces the following meeting of the aforementioned committee. The meeting announced below concerns Conducting Public Health Research in South Africa, Funding Opportunity Announcement (FOA) GH12–004, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 8:30 a.m.–3 p.m. (EDT), April 26, 2012. Place: CDC, 1600 Clifton Road NE., Building 21, Rooms 1204 A/B, Atlanta, Georgia 30333. This meeting is also available by teleconference. Please dial (877) 930–8819 and enter code 1579739. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 50 people. To accommodate public participation in the meeting, a conference telephone line will be available. The public is welcome to participate during the public comment period. The public comment period is tentatively scheduled from 2:45 p.m. until 2:50 p.m. Purpose: The committee will provide advice to the CDC Director on strategic and other broad issues facing CDC. Matters To Be Discussed: The Advisory Committee to the Director will receive updates from the Global Workgroup; State, Tribal, Local and Territorial Workgroup; the Policy Workgroup; the Communications Workgroup; the Ethics Subcommittee, and the Health Disparities Subcommittee, as well as an update from the CDC Director. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Carmen Villar, MSW, Designated Federal Officer, Advisory Committee to the Director, CDC, 1600 Clifton Road NE., M/S D–14, Atlanta, Georgia 30333, telephone 404/639– 7000, email: GHickman@cdc.gov. The deadline for notification of attendance is April 20, 2012. To register for this meeting, please send an email to ACDirector@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. PO 00000 Frm 00022 Fmt 4703 Sfmt 9990 Time and Date: 12 p.m.–4 p.m., May 2, 2012 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Conducting Public Health Research in South Africa, FOA GH12–004.’’ Contact Person for More Information: Lata Kumar, Scientific Review Officer, CGH Science Office, Center for Global Health, CDC, 1600 Clifton Road NE., Mailstop D–69, Atlanta, Georgia 30033, Telephone (404) 639–7618. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: March 22, 2012. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2012–7545 Filed 3–28–12; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\29MRN1.SGM 29MRN1

Agencies

[Federal Register Volume 77, Number 61 (Thursday, March 29, 2012)]
[Notices]
[Page 19018]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-7545]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Conducting Public Health 
Research in South Africa, Funding Opportunity Announcement (FOA) GH12-
004, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 12 p.m.-4 p.m., May 2, 2012 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Conducting Public Health Research in South Africa, FOA 
GH12-004.''
    Contact Person for More Information: Lata Kumar, Scientific 
Review Officer, CGH Science Office, Center for Global Health, CDC, 
1600 Clifton Road NE., Mailstop D-69, Atlanta, Georgia 30033, 
Telephone (404) 639-7618.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: March 22, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-7545 Filed 3-28-12; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.